ZUG, Switzerland, Aug. 03, 2026 (GLOBE NEWSWIRE) -- The FDA Division of Neurology provided positive feedback supporting a regulatory pathway...
Speech-language pathologist Sanna Darwish says understanding how a brain works, not just what diagnosis it may carry, could reshape the...
Beginning August 1, 2026, individuals and families will be able to access SimpleC's personalized Companion platform directly for use at...
Ad hoc announcement pursuant to Art. 53 LR QUVIVIQ™ (daridorexant) sales reached CHF 91 million in H1 2026, up 62%...
Developed by trauma psychologist Jenny Hughes, PhD, the evidence-informed training gives groups, agencies, and organizations a shared framework for building...
LAS VEGAS, NV / ACCESS Newswire / July 29, 2026 / BioAdaptives, Inc. (OTCID:BDPT), a developer of natural, science-backed wellness...
Consolidated net revenue of € 1,410.8 million in the first half of 2026, +6.6% or +9.1% on a like-for-like basis(3)...
The company has given families nationwide access to $33 million in benefits, covering out-of-pocket costs for care from hospital stays...
SHELTON, CT / ACCESS Newswire / July 28, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
Vancouver, British Columbia--(Newsfile Corp. - July 27, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"),...
Delivers Fourth Consecutive Quarter of Positive Adjusted EBITDA HACKENSACK, NJ / ACCESS Newswire / July 27, 2026 / Champions Oncology,...
Exclusive agreement with Jamjoom Pharma covers commercialization and distribution of QUVIVIQ™ (daridorexant) in Saudi Arabia and the Levant region Allschwil,...
Cogni Honey Publishes Updated Ingredient, Serving, Label, and Safety Information for Its Current Dietary Supplement FormulaLargo, FL, July 25, 2026...
Group sales were +6% at constant exchange rates (CER)1, -2% when reported in CHF and +8% in USD2, in the...
MIDDLETOWN, CT / ACCESS Newswire / July 22, 2026 / Aware Recovery Care, a national leader in in-home and virtual...
SHELTON, CT / ACCESS Newswire / July 22, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
Intra-operative Study with TU Munich Klinikum Rechts der Isar for First Use of ABILITY's Technology to Record Signals from the...
Artificial Intelligence model added to new update of Europe's most widely used EEG software platform MIDDLETON, Wis., July 21, 2026...
The article outlines thyroid symptoms, thyroid blood testing, and how to prepare for a productive thyroid visit.LAFAYETTE, Ind., July 20,...
Mission Therapeutics has divested MTX652, a Phase 2-ready selective USP30 inhibitor for Acute Kidney Injury (AKI), to ASX-listed renal specialist...